377220 — From Bio Co Income Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesSpeculativeMicro CapNeutral

Annual income statement for From Bio Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	Annual Audited Accounts	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	61,879	108,045	135,103	99,330	66,724
Cost of Revenue
Gross Profit	48,142	85,019	102,104	69,309	45,955
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	56,827	88,102	123,762	98,533	82,239
Operating Profit	5,052	19,943	11,341	797	-15,515
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-20,879	-4,014	11,638	1,512	-15,740
Provision for Income Taxes
Net Income After Taxes	-21,025	-7,813	11,282	1,318	-11,609
Minority Interest
Net Income Before Extraordinary Items
Net Income	-21,025	-7,813	11,282	3,241	-11,076
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-21,025	-7,813	11,282	3,241	-11,076
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-753	-257	464	118	-389
Dividends per Share